These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 8243568)

  • 1. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
    Lemoli RM; Strife A; Clarkson BD; Haley JD; Gulati SC
    Exp Hematol; 1992 Dec; 20(11):1252-6. PubMed ID: 1493854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of highly proliferative colony forming cells after treatment of bone marrow cells with 4-hydroperoxycyclophosphamide.
    Komatsu N; Suda T; Suda J; Miura Y
    Cancer Res; 1987 Dec; 47(23):6371-6. PubMed ID: 3677081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
    Gallicchio VS; Casale GP; Watts T
    Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced oxygen tension increases hematopoiesis in long-term culture of human stem and progenitor cells from cord blood and bone marrow.
    Koller MR; Bender JG; Miller WM; Papoutsakis ET
    Exp Hematol; 1992 Feb; 20(2):264-70. PubMed ID: 1544397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine erythroid (CFU-E, BFU-E) and granulocyte-macrophage colony formation in culture.
    Fritsch G; Nelson RT
    Exp Hematol; 1990 Mar; 18(3):195-200. PubMed ID: 2303113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor cells.
    Hangoc G; Falkenburg JH; Broxmeyer HE
    Exp Hematol; 1991 Aug; 19(7):697-703. PubMed ID: 1893956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide.
    Rowley SD; Colvin OM; Stuart RK
    Exp Hematol; 1985 May; 13(4):295-8. PubMed ID: 3987832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H; Guilbert LJ; Janowska-Wieczorek A
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of natural killer cells on modulating CFU-Meg and BFU-E proliferation in situ.
    Pantel K; Nakeff A
    Exp Hematol; 1989 Nov; 17(10):1017-21. PubMed ID: 2806434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.